Global Single-Photon Emission Computed Tomography (SPECT) Market
Medical Equipment

How is the Single-Photon Emission Computed Tomography (SPECT) Market Poised for Growth: Trends and Opportunities Through 2034

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the single-photon emission computed tomography (spect) market size evolved in recent years?

The market size for single-photon emission computed tomography (SPECT) has been significantly expanding in the past few years. The market value is predicted to rise from $2.37 billion in 2024 to $2.53 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. Factors such as increasing diagnostic imaging necessities, a surge in chronic disease incidence, progress in radiopharmaceuticals, an enlarging elderly population, and heightened healthcare spending can be credited for the growth experienced in the historic period.

What are the predictions for the single-photon emission computed tomography (spect) market size in the coming years?

Expectations are high for substantial expansion in the single-photon emission computed tomography (SPECT) market size over the next few years. The market is predicted to achieve a value of $3.59 billion in 2029, which represents a compound annual growth rate (CAGR) of 9.2%. This growth during the projection period is largely attributed to an increased focus on precision medicine, broader uses in neurological imaging, worldwide increase in cancer cases, progress in radiotracer technology, and its incorporation into multi-modal imaging systems. The forthcoming period will feature key trends such as improved image reconstruction methods, the rise of mobile SPECT imaging services, a reinforced focus on cardiac imaging, advancements in detector technology, and a surge in clinical research initiatives.

Get your single-photon emission computed tomography (spect) market report here!

https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report

What key factors are fueling the growth of the single-photon emission computed tomography (spect) market?

The single-photon emission computed tomography (SPECT) market is predicted to expand due to an increase in cancer incidence. This surge in cancer cases stems from an aging population, unhealthy lifestyle decisions, and environmental influences. Single-photon emission computed tomography (SPECT) aids in cancer diagnosis, staging, and monitoring, in conjunction with other imaging methods such as computed tomography (CT) and Magnetic Resonance Imaging (MRI) scans. To exemplify, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported in September 2023 that of the 41 million deaths globally due to non-communicable diseases (NCDs) or chronic diseases every year, 74% were from cardiovascular diseases (17.9 million), cancer (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million). Consequently, the escalating incidence of cancer cases is fueling the growth of the single-photon emission computed tomography (SPECT) market.

How is the global single-photon emission computed tomography (spect) market divided into key segments?

The single-photon emission computed tomography (SPECT) market covered in this report is segmented –

1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems

2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes

3) By Application: Oncology, Cardiology, Neurology, Other Applications

4) By End User: Hospitals, Diagnostic Centers, Other End User

Subsegments:

1) By Hybrid SPECT Systems: SPECT Or CT Systems, SPECT Or MRI Systems

2) By Standalone SPECT Systems: Single-Head SPECT Systems, Multi-Head SPECT Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9960&type=smp

Who are the key firms paving the way for growth in the single-photon emission computed tomography (spect) market?

Major companies operating in the single-photon emission computed tomography (SPECT) market include GE Healthcare Technologies Inc., Siemens AG, Digirad Corporation, Mediso Ltd., Bracco Diagnostic SpA, Cardinal Health Inc., Curium Pharma UK Ltd., Spectrum Dynamics Medical Inc., Koninklijke Philips N.V., Beijing Hamamatsu Photon Techniques Inc., Canon Medical Systems Corporation, Esaote S.p.A., MR Solutions Ltd., TriFoil Imaging Inc., Gamma Medica Inc., Guerbet SA, Lantheus Medical Imaging Inc., Neusoft Medical Systems Co. Ltd., Cubresa Inc., NeuroLogica Corp.

Which trends are expected to transform the single-photon emission computed tomography (spect) market?

Advancements in technology are increasingly becoming a major trend in the single-photon emission computed tomography (SPECT) market. Firms in this market are embracing high-resolution imaging innovations to maintain their market position. For example, Siemens Healthcare, a Germany-based company that manufactures medical devices and solutions, introduced the Symbia Pro. Spectra SPECT/CT Scanner in June 2022. This device includes state-of-the-art imaging technology, enhanced accessibility, optimal low-dose imaging, automatic SPECT motion correction, and personalized clinical tools for cardiology, oncology, orthopedics, and neurology applications. Additionally, this device comes with the myExam Companion feature, aimed at automating workflow guidance.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9960

What regions are contributing significantly to the growth of the single-photon emission computed tomography (spect) market?

North America was the largest region in the single-photon emission computed tomography (SPECT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the single-photon emission computed tomography (SPECT) market report during the forecast period. The regions covered in the single-photon emission computed tomography (spect) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Pain Management Devices And Therapies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Convalescent Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Wound Care Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/wound-care-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: